AVALO THERAPEUTICS INC (AVTX)

US05338F2074 - Common Stock

0.1414  -0.03 (-16.53%)

After market: 0.1347 -0.01 (-4.74%)

AVALO THERAPEUTICS INC

NASDAQ:AVTX (9/28/2023, 6:29:07 PM)

After market: 0.1347 -0.01 (-4.74%)

0.1414

-0.03 (-16.53%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-03 2023-08-03/bmo
Earnings (Next)11-06 2023-11-06/bmo
Ins Owners0.23%
Inst Owners11.59%
Market Cap2.96M
Shares20.95M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts43.33
IPO11-13 2015-11-13
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AVTX Daily chart

Company Profile

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. The company is headquartered in Rockville, Maryland and currently employs 20 full-time employees. The company went IPO on 2015-11-13. The firm is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. Its clinical-stage pipeline includes AVTX-002, AVTX-008, and AVTX-803 programs. AVTX-002 is an Anti-LIGHT monoclonal antibody for treatment of non-eosinophilic asthma, Crohn’s Disease, and COVID-19 acute respiratory distress syndromes. AVTX-008 is a fully human B and T lymphocyte attenuator (BTLA) agonist fusion protein that is being evaluated for several immune dysregulation disorders. AVTX-803 is a monosaccharide therapy for the treatment of leukocyte adhesion deficiency type II (LAD II), which is a congenital disorder of glycosylation (CDG).

Company Info

AVALO THERAPEUTICS INC

540 Gaither Rd Ste 400

Rockville MARYLAND

P: 14105228707.0

CEO: Michael Cola

Employees: 20

Website: https://www.avalotx.com/

AVTX News

News Image3 hours ago - ChartmillDiscover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

News Image6 hours ago - ChartmillThese stocks are making the most noise in today's session. Stay tuned for the latest updates!

These stocks are the most active in today's session

News Image11 hours ago - ChartmillThursday's pre-market session: top gainers and losers

Pre-market stock analysis on 2023-09-28: top gainers and losers in today's session.

News Imagea day ago - ChartmillDiscover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume!

Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

News Imagea day ago - TheNewswire.comBestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics

NEW YORK, NY / NewsDirect / September 27th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued an extensive analysis on Avalo Therapeutics Inc a clinical-stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.

News Image2 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

AVTX Twits

Here you can normally see the latest stock twits on AVTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example